SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-125670
Filing Date
2011-05-04
Accepted
2011-05-04 12:56:30
Documents
11
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 422774
2 ACCELERATED SHARE REPURCHASE PROGRAM AGREEMENT, DATED MARCH 1, 2011 dex101.htm EX-10.1 155147
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9781
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9987
5 SECTION 906 CEO AND CFO CERTIFICATION dex321.htm EX-32.1 4501
11 GRAPHIC g175854g60r65.jpg GRAPHIC 4464
  Complete submission text file 0001193125-11-125670.txt   2184710

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mygn-20110331.xml EX-101.INS 268958
7 XBRL TAXONOMY EXTENSION SCHEMA mygn-20110331.xsd EX-101.SCH 11603
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mygn-20110331_cal.xml EX-101.CAL 35900
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20110331_lab.xml EX-101.LAB 118331
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20110331_pre.xml EX-101.PRE 75053
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 11809256
SIC: 2835 In Vitro & In Vivo Diagnostic Substances